Spinal anesthesia for cesarean section in a patient with systemic sclerosis associated interstitial lung disease-a case report-

被引:1
|
作者
Lee, Guie Yong [1 ]
Cho, Sooyoung [1 ]
机构
[1] Ewha Womans Univ, Sch Med, Dept Anesthesiol & Pain Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea
关键词
Cesarean section; Interstitial lung disease; Spinal anesthesia; Systemic scleroderma;
D O I
10.4097/kjae.2016.69A.406
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Systemic sclerosis or scleroderma is a rare autoimmune disorder characterized by excessive fibrosis and, vasculopathy, with multiorgan involvement. Anesthetic considerations in patients with systemic sclerosis must take into account the degree of organ dysfunction as well as airway management. Regional anesthesia is a preferable alternative to general anesthesia despite the reports of prolonged sensory block. Spinal anesthesia in patients with systemic sclerosis has been reported for only one patients undergoing cesarean section. Concurrent systemic sclerosis and pregnancy raise many obstetric and anesthetic considerations. We describe the case of a pregnant patient with systemic sclerosis who had a history of dyspnea and interstitial lung disease. The cesarean section was performed uneventfully under spinal anesthesia.
引用
收藏
页码:406 / 408
页数:3
相关论文
共 50 条
  • [41] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Distler, Oliver
    Highland, Kristin B.
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen D.
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Tetzlaff, Kay
    Kuwana, Masataka
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26): : 2518 - 2528
  • [42] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [43] Management of Systemic-Sclerosis-Associated Interstitial Lung Disease
    Silver, Katherine Culp
    Silver, Richard M.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (03) : 439 - +
  • [44] Ethnic Variations in Systemic Sclerosis Associated Interstitial Lung Disease
    Donio, Patrick
    Fidler, Wesley
    Diaz-Martinez, Juan Pablo
    Bangert, Elvira
    Ahmad, Zareen
    Soowamber, Medha
    Johnson, Sindhu
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1303 - 1304
  • [45] Experience with azathioprine in systemic sclerosis associated with interstitial lung disease
    Dheda, K
    Lalloo, UG
    Cassim, B
    Mody, GM
    CLINICAL RHEUMATOLOGY, 2004, 23 (04) : 306 - 309
  • [46] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [47] Breathomics to monitor interstitial lung disease associated with systemic sclerosis
    Massenet, Thibault
    Potjewijd, Judith
    Tobal, Rachid
    Gester, Fanny
    Zanella, Delphine
    Henket, Monique
    Njock, Makon-Sebastien
    Dejong, Thibaut
    Gridelet, Gregory
    Giltay, Laurie
    Guissard, Francoise
    Andre, Beatrice
    Ribbens, Clio
    Louis, Renaud
    Van Paassen, Pieter
    Guiot, Julien
    Stefanuto, Pierre-Hugues
    ERJ OPEN RESEARCH, 2024, 10 (04)
  • [48] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (11): : E755 - E755
  • [49] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Rahimi, Susan
    LANCET RESPIRATORY MEDICINE, 2020, 8 (02): : 136 - 136
  • [50] Pharmacological management of systemic sclerosis associated interstitial lung disease
    Dixon, Giles
    Adamali, Ibrahim
    Adamali, Huzaifa
    Barratt, Shaney
    Gunarwardena, Harsha
    Pauling, John D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (07) : 815 - 824